Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
Breast Cancer (Tokyo, Japan)|May 13, 2015
Fc-Gamma receptor polymorphism and gene expression of peripheral blood mononuclear cells in patients with HER2-positive metastatic breast cancer receiving single-agent trastuzumabChikako Shimizu, Kaoru Mogushi, Masaki Suimye Morioka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Genetic testing for effective Herceptin therapy]Toru Watanabe, Noriyuki Katsumata, Masashi Ando, et al.
Oncology Reports|February 13, 2009
Primary tumor resection improves the survival of younger patients with metastatic breast cancerTadahiko Shien, Takayuki Kinoshita, Chikako Shimizu, et al.
Japanese Journal of Clinical Oncology|May 30, 2009
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancerChikako Shimizu, Norikazu Masuda, Kenichi Yoshimura, et al.
Gynecologic Oncology|November 22, 2005
The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancerKoji Matsumoto, Noriyuki Katsumata, Yasuhiro Yamanaka, et al.
International Journal of Clinical Oncology|February 25, 2014
Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patientsChikako Shimizu, Tomoyasu Kato, Nobuko Tamura, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2010
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapyMaki Tanioka, Noriyuki Katsumata, Kan Yonemori, et al.
Case Reports in Oncology|February 3, 2022
A Case of Recurrent Ovarian Cancer and Therapy-Related Acute Myeloid Leukemia Treated with AzacitidineKenju Ando, Akihiko Shimomura, Ryo Nasu, et al.
Plos One|September 7, 2012
Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journalKan Yonemori, Akihiro Hirakawa, Masashi Ando, et al.
International Journal of Breast Cancer|January 3, 2014
Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete ResponseJunichi Asano, Akihiro Hirakawa, Chikuma Hamada, et al.
Pageof 23